Christopher Banks: Driving Success with 79% Year-Over-Year Spring Sales Growth and Expansion Plans for Fall 2022

Christopher Banks: Driving Success with 79% Year-Over-Year Spring Sales Growth and Expansion Plans for Fall 2022 MINNEAPOLIS, Aug. 09, 2022 (GLOBE NEWSWIRE) — iMedia Brands, Inc. (“iMedia” or the “Company”) (NASDAQ: IMBI, IMBIL) Christopher & Banks, a 65-year-old iconic brand, has been on a trajectory of success with a remarkable 79% year-over-year growth in net…

Read More

Breaking News: Infinera Successfully Completes $373.75 Million Convertible Senior Notes Offering and Repurchases $300 Million of 2024 Convertible Notes

Breaking News: Infinera Successfully Completes $373.75 Million Convertible Senior Notes Offering and Repurchases $300 Million of 2024 Convertible Notes SAN JOSE, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) announced today the closing of its previously announced offering of 3.75% convertible senior notes due 2028 (the “2028 Notes”) in a private placement to…

Read More

Unlocking the Power of Pepinemab: A Breakthrough Study in Huntington’s Disease Published in Nature Medicine

Slow Down Cognitive Decline with Pepinemab A Game-Changing Treatment for Neurodegenerative Diseases By: Your Name Here Have you ever worried about your cognitive health as you age? With the recent news from Vaccinex, Inc. about pepinemab’s potential to slow or prevent cognitive decline in Huntington’s Disease, there is hope on the horizon for those facing…

Read More